Newborn Screening for Hemoglobin Disorders
Clinics in Perinatology · 2025
DOI: 10.1016/j.clp.2025.06.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Perinatology, 2025. Verfasst von Bradford L Therrell. Beteiligte Einrichtung: Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; U.S. National Newborn Screening and G…. Hauptthemen laut MEDLINE: Neonatal Screening, Hemoglobinopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Newborn screening for hemoglobinopathies began in New York in 1975. It has evolved through the years to include case detection not only for sickle cell diseases but also for many other clinically significant hemoglobin disorders. Hemoglobinopathy screening outside of the U.S. and parts of Europe are limited. Their absence in high prevalence areas of sickle cell diseases such as Sub-Saharan Africa, the Caribbean Islands and India illustrate the global inequities. Newborn screening for alpha-thalassemias is also limited. This report reviews some of the history of newborn screening for hemoglobinopathies and thalassemias and provides an update of related activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; U.S. National Newborn Screening and Global Resource Center, 3907 Galacia Drive, Austin, TX 78759, USA. Elec…
Zitieren
APA
Therrell, B. L. (2025). Newborn Screening for Hemoglobin Disorders. Clinics in Perinatology. https://doi.org/10.1016/j.clp.2025.06.007
Vancouver
Therrell BL. Newborn Screening for Hemoglobin Disorders. Clinics in Perinatology. 2025. doi:10.1016/j.clp.2025.06.007
BibTeX
@article{Therrell2025,
author = {Therrell, Bradford L},
title = {Newborn Screening for Hemoglobin Disorders},
journal = {Clinics in Perinatology},
year = {2025},
doi = {10.1016/j.clp.2025.06.007}
}
EUVIMED